Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
V. Theobald (Heidelberg, Germany), E. Grünig (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), H. Gall (Gießen, Germany), A. Ghofrani (Gießen, Germany), M. Halank (Dresden, Germany), S. Harutyunova (Heidelberg, Germany), M. Hoeper (Hannover, Germany), D. Jonigk (Hannover, Germany), M. Schneider (Heidelberg, Germany), H. Seyfarth (Leipzig, Germany), S. Richtmann (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), M. Muckenthaler (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany). BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients. 587

Member's Comments

No comment yet.

Related content which might interest you: Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Screening of pulmonary arterial hypertension in BMPR2 mutation carriers Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 1195-1198 Year: 2014 BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1668-1681 Year: 2016 Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Iron deficiency is common in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2011; 37: 1386-1391 Year: 2011 Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation Source: Eur Respir J 2007; 30: Suppl. 51, 250s Year: 2007 Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient Source: Eur Respir Rev 2014; 23: 147-149 Year: 2014 Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation Source: Eur Respir J 2012; 39: 1534-1535 Year: 2012 Iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Source: Eur Respir J 2011; 38: 1453-1460 Year: 2011 Molecular analysis of genes BMPR2 and KCNA5 in Spanish patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Protein truncating mutations in ATP13A3 promote pulmonary arterial hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Familial pulmonary arterial hypertension by KDR heterozygous loss of function Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019 Year: 2020 CFTR involvement in the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 770 Year: 2009 Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation Source: Eur Respir J, 55 (5) 1902340; 10.1183/13993003.02340-2019 Year: 2020